These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 9209643

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.
    Sarris AH, Luthra R, Papadimitracopoulou V, Waasdorp M, Dimopoulos MA, McBride JA, Cabanillas F, Duvic M, Deisseroth A, Morris SW, Pugh WC.
    Blood; 1996 Sep 01; 88(5):1771-9. PubMed ID: 8781434
    [Abstract] [Full Text] [Related]

  • 3. Genomic DNA amplification and the detection of t(2;5)(p23;q35) in lymphoid neoplasms.
    Sarris AH, Luthra R, Cabanillas F, Morris SW, Pugh WC.
    Leuk Lymphoma; 1998 May 01; 29(5-6):507-14. PubMed ID: 9643564
    [Abstract] [Full Text] [Related]

  • 4. Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease.
    Wellmann A, Otsuki T, Vogelbruch M, Clark HM, Jaffe ES, Raffeld M.
    Blood; 1995 Sep 15; 86(6):2321-8. PubMed ID: 7662979
    [Abstract] [Full Text] [Related]

  • 5. Mapping of genomic t(2;5)(p23;q35) break points in patients with anaplastic large cell lymphoma by sequencing long-range PCR products.
    Luthra R, Pugh WC, Waasdorp M, Morris W, Cabanillas F, Chan PK, Sarris AH.
    Hematopathol Mol Hematol; 1998 Sep 15; 11(3-4):173-83. PubMed ID: 9844824
    [Abstract] [Full Text] [Related]

  • 6. Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis.
    Beylot-Barry M, Lamant L, Vergier B, de Muret A, Fraitag S, Delord B, Dubus P, Vaillant L, Delaunay M, MacGrogan G, Beylot C, de Mascarel A, Delsol G, Merlio JP.
    Am J Pathol; 1996 Aug 15; 149(2):483-92. PubMed ID: 8701987
    [Abstract] [Full Text] [Related]

  • 7. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
    Drexler HG, Gignac SM, von Wasielewski R, Werner M, Dirks WG.
    Leukemia; 2000 Sep 15; 14(9):1533-59. PubMed ID: 10994999
    [Abstract] [Full Text] [Related]

  • 8. Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease.
    Wood GS, Hardman DL, Boni R, Dummer R, Kim YH, Smoller BR, Takeshita M, Kikuchi M, Burg G.
    Blood; 1996 Sep 01; 88(5):1765-70. PubMed ID: 8781433
    [Abstract] [Full Text] [Related]

  • 9. The use of fluorescent in situ hybridization for detection of the t(2;5)(p23;q35) translocation in anaplastic large-cell lymphoma.
    Johnson PW, Leek J, Swinbank K, Angus B, Roberts P, Markham AF, Selby PJ, MacLennan KA.
    Ann Oncol; 1997 Sep 01; 8 Suppl 2():65-9. PubMed ID: 9209644
    [Abstract] [Full Text] [Related]

  • 10. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.
    Pittaluga S, Wlodarska I, Pulford K, Campo E, Morris SW, Van den Berghe H, De Wolf-Peeters C.
    Am J Pathol; 1997 Aug 01; 151(2):343-51. PubMed ID: 9250148
    [Abstract] [Full Text] [Related]

  • 11. The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines.
    Dirks WG, Zaborski M, Jäger K, Challier C, Shiota M, Quentmeier H, Drexler HG.
    Leukemia; 1996 Jan 01; 10(1):142-9. PubMed ID: 8558920
    [Abstract] [Full Text] [Related]

  • 12. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining.
    Lamant L, Meggetto F, al Saati T, Brugières L, de Paillerets BB, Dastugue N, Bernheim A, Rubie H, Terrier-Lacombe MJ, Robert A, Rigal F, Schlaifer D, Shiuta M, Mori S, Delsol G.
    Blood; 1996 Jan 01; 87(1):284-91. PubMed ID: 8547653
    [Abstract] [Full Text] [Related]

  • 13. Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions.
    Elmberger PG, Lozano MD, Weisenburger DD, Sanger W, Chan WC.
    Blood; 1995 Nov 01; 86(9):3517-21. PubMed ID: 7579458
    [Abstract] [Full Text] [Related]

  • 14. The t(2;5) in human lymphomas.
    Kadin ME, Morris SW.
    Leuk Lymphoma; 1998 Apr 01; 29(3-4):249-56. PubMed ID: 9684923
    [Abstract] [Full Text] [Related]

  • 15. Molecular characterization of the t(2;5) (p23; q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease.
    Yee HT, Ponzoni M, Merson A, Goldstein M, Scarpa A, Chilosi M, Menestrina F, Pittaluga S, de Wolf-Peeters C, Shiota M, Mori S, Frizzera G, Inghirami G.
    Blood; 1996 Feb 01; 87(3):1081-8. PubMed ID: 8562933
    [Abstract] [Full Text] [Related]

  • 16. Reverse transcriptase polymerase chain reaction for the Ki-1 anaplastic large cell lymphoma-associated t(2;5) translocation in Hodgkin's disease.
    Ladanyi M, Cavalchire G, Morris SW, Downing J, Filippa DA.
    Am J Pathol; 1994 Dec 01; 145(6):1296-300. PubMed ID: 7527617
    [Abstract] [Full Text] [Related]

  • 17. Molecular analysis of the NPM-ALK rearrangement in Hodgkin's disease.
    Xerri L, Parc P, Hassoun J, Birnbaum D.
    J Pathol; 1996 Feb 01; 178(2):128-32. PubMed ID: 8683377
    [Abstract] [Full Text] [Related]

  • 18. Analysis of the t(2;5) (p23;q35) translocation in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease.
    Wood GS.
    Leuk Lymphoma; 1998 Mar 01; 29(1-2):93-101. PubMed ID: 9638979
    [Abstract] [Full Text] [Related]

  • 19. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin.
    DeCoteau JF, Butmarc JR, Kinney MC, Kadin ME.
    Blood; 1996 Apr 15; 87(8):3437-41. PubMed ID: 8605362
    [Abstract] [Full Text] [Related]

  • 20. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1.
    Pulford K, Lamant L, Morris SW, Butler LH, Wood KM, Stroud D, Delsol G, Mason DY.
    Blood; 1997 Feb 15; 89(4):1394-404. PubMed ID: 9028963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.